Antibody composition with altered Fab sialylation

Details for Australian Patent Application No. 2010229713 (hide)

Owner CSL Behring AG University of Washington

Inventors Kasermann, Fabian; Ruegsegger, Monika; Miescher, Sylvia; Elkon, Keith

Agent Watermark

Pub. Number AU-A-2010229713

PCT Pub. Number WO2010/111633

Priority 09004358.9 26.03.09 EP

Filing date 26 March 2010

Wipo publication date 30 September 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 1/22 (2006.01) General processes for the preparation of peptides

Event Publications

20 October 2011 PCT application entered the National Phase

  PCT publication WO2010/111633 Priority application(s): WO2010/111633

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010229721-Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis

2010229711-Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds